fsp1 is a glutathione-independent ferroptosis suppressor. Upregulation of CoQ shifts dependence from GPX4 to in acquired radioresistance FSP1-mediated ferroptosis in cancer: from

Finally, degradation/release pathways depict the release mechanism, where PLGA nanoparticles degrade under high GSH conditions, releasing the drug to exert its therapeutic effect selectively within tumor cells

Tt c cc sn phm ca hng u c kim nh cht lng kht khe bi bn th 3 trc khi bn ra th trng

e , Proteasome purifications from the cytosol of livers from 20S-FLAG/BAF53b-Cre mice

When I conduct my assays, should I select the V-bottom or filter plate option

Cell Death Differ 29:10941106 Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, Korenfeld D, Mathyer ME, Kim H, Huang LH, Duncan D, Bregman H, Keskin A, Santeford A, Apte RS, Sehgal R, Johnson B, Amarasinghe GK, Soares MP, Satoh T, Akira S, Hai T, de Guzman SC, Auclair K, Roddy TP, Biller SA, Jovanovic M, Klechevsky E, Stewart KM, Randolph GJ, Artyomov MN (2018) Electrophilic properties of itaconate and derivatives regulate the ikappabzeta-atf3 inflammatory axis